scieee Science in your language
[en] (orig)

Hydroxytyrosol and tyrosol sulfate metabolites protect against the oxidized cholesterol pro-oxidant effect in Caco-2 human enterocyte-like cells

Abstract

The aim of this study was to investigate the ability of the sulfate metabolites of hydroxytyrosol (HT) and tyrosol (TYR) to act as antioxidants counteracting the pro-oxidant effect of oxidized cholesterol in intestinal cells. For this purpose, we synthesized sulfate metabolites of HT and TYR using a chemical methodology and examined their antioxidant activity in Caco-2 monolayers in comparison with the parent compounds. Exposure to oxidized cholesterol led to ROS production, oxidative damage, as indicated by the MDA increase, a decrease of reduced glutathione concentration and an enhancement of glutathione peroxidase activity. All the tested compounds were able to counteract the oxidizing action of oxidized cholesterol; HT and TYR sulfate metabolites showed an efficiency in protecting intestinal cells comparable to that of the parent compounds, strengthening the assumption that the potential beneficial effect of the parent compounds is retained, although extensive metabolisation occurs, the resulting metabolites being able to exert a biological action themselves.

Read accessible full text

Hydroxytyrosol and tyrosol sulfate metabolites protect against the oxidized cholesterol pro-oxidant effect in Caco-2 human enterocyte-like cells

Author: Atzeri, Angela; Lucas Rodríguez, Ricardo; Incani, Alessandra; Peñalver, Pablo; Zafra-Gómez, Alberto; Melis, M. Paola; Pizzala, Roberto; Morales, Juan C.; Deiana, Monica
Publisher: Royal Society of Chemistry
Year: 2016
DOI: 10.1039/C5FO00074B
Source: https://idus.us.es/bitstreams/85813a7b-8a8f-4cb3-a0fb-36669db7e052/download
Food & Func ion
Ci e his: DOI: 10.1039/c0xx00000x
www. sc.o g/xxxxxx
Dynamic A icle Links ►
ARTICLE TYPE
This jou nal is © The Royal Socie y o Chemis y [yea ] [jou nal], [yea ], [ ol], 00–00 | 1
Hyd oxy y osol and y osol sul a e me aboli es p o ec agains oxidized
choles e ol p o-oxidan e ec in Caco-2 human en e ocy e-like cells.
Angela A ze ia, Rica do Lucasb, Alessand a Incania, Pablo Peñal e c, Albe o Za a-Gómezd, M. Paola
Melisa, Robe o Pizzalae, Juan C. Mo alesb,c* and Monica Deianaa*
Recei ed (in XXX, XXX) X h XXXXXXXXX 20XX, Accep ed X h XXXXXXXXX 20XX
5
DOI: 10.1039/b000000x
Abs ac
The aim o his s udy was o in es iga e he abili y o sul a e me aboli es o hyd oxy y osol (HT) and
y osol (TYR) o ac as an ioxidan s coun e ac ing he p o-oxidan e ec o oxidized choles e ol in
in es inal cells. Fo his pu pose, we syn hesized sul a e me aboli es o HT and TYR using chemical
10
me hodology and examined hei an ioxidan ac i i y in Caco-2 monolaye s in compa ison wi h he pa en
compounds. Exposu e o oxidized choles e ol led o ROS p oduc ion, oxida i e damage, as indica ed by
MDA inc ease, a dec ease o educed glu a hione concen a ion and an enhancemen o glu a hione
pe oxidase ac i i y. All he es ed compounds we e able o coun e ac he oxidizing ac ion o oxidized
choles e ol; HT and TYR sul a e me aboli es showed an e iciency in p o ec ing in es inal cells
15
compa able o ha o he pa en compounds, s eng hening he assump ion ha he po en ial bene icial
e ec o he pa en compounds is e ained, al hough ex ensi e me abolisa ion occu s, being he esul ing
me aboli es able o exe a biological ac ion hemsel es.
Keywo ds:
20
sul a e me aboli es, oxida i e s ess, oxidized choles e ol, oli e oil phenolic compounds
CREATED USING THE RSC ARTICLE TEMPLATE (VER. 3.0) - SEE WWW.RSC.ORG/ELECTRONICFILES FOR DETAILS
ARTICLE TYPE www. sc.o g/xxxxxx | XXXXXXXX
2
| Jou nal Name, [yea ],
[ ol]
, 00–00
This jou nal is © The Royal Socie y o Chemis y [yea ]
In oduc ion
Polyphenols p esen in ex a i gin oli e oil, he p incipal a componen o he Medi e anean die , ha e been demons a ed o exe
many po en ially bene icial biological e ec s due o, a leas in pa , hei abili y o p o ec agains oxida i e s ess media ed damage 1-2.
Hyd oxy y osol (3,4-dihyd oxyphenyle hanol; HT) and y osol (4-hyd oxyphenyle hanol; TYR) (Fig. 1) a e he mos biologically ac i e
phenolic alcohols p esen in he oil, whe e hey exis in simple o ms o as conjuga es (such as oleu opein); hey a e s uc u ally iden ical
5
excep ha HT has an ex a hyd oxyl g oup in he me a posi ion.
10
Fig. 1 S uc u e o y osol (TYR), hyd oxy y osol (HT) and hei sul a e me aboli es 3-5
The li e a u e on phenolic abso p ion and me abolism a e oli e oil inges ion is ex ensi e 3-4; howe e , he e a e s ill se e al issues o be
cla i ied. Some complex oli e oil polyphenols, among he secoi idoids, a e ela i ely s able unde gas ic condi ions and each he
15
in es ine whe e hey may be di ec ly abso bed o me abolised unde abso p ion5; mos o he complex oli e oil polyphenols howe e
seems o unde go gas oin es inal bio ans o ma ion (see de Bock o an excellen e iew ) 6, inc easing he ela i e amoun o simple
phenols, mainly TYR and HT, en e ing he small and la ge in es ine 7. A his loca ion he concen a ion o simple phenols may be qui e
high, in he high M ange 7, and hey migh exe di ec p o ec i e e ec s by sca enging eac i e species and/o p e en ing hei
o ma ion 8. Howe e , in he p ocess o c ossing en e ocy es oli e oil phenolic compounds a e subjec ed o classical phase I/II
20
bio ans o ma ion and o an impo an i s pass me abolism, esul ing in almos unde ec able concen a ions o ee HT and TYR in body
luids 9.
Sul a ed and glucu onida ed HT and TYR a e he p edominan me aboli es ound in human plasma and u ine 10-11, and hey ha e also
been shown o concen a e in he in es inal epi helium, since glucu onida ion and sul a ion a e he majo pa hways o phase II xenobio ic
me abolism in he human in es ine 12-13. The po en ial heal h bene i s o HT, TYR and hei de i a i es a e likely o be due o bo h
25
pa en al compounds and hei phase I and phase II majo me aboli es. Glucu onida ed me aboli es o HT showed a mo e e icien adical
sca enging po ency han HT i sel 11 and he abili y o p o ec enal cells 14 and e y h ocy es om oxida i e inju y was also be e han
he pa en compound 15. Howe e no da a a e a ailable up- o-da e conce ning he an ioxidan ac i i y o sul a e me aboli es o HT and
TYR.
In his s udy we in es iga ed he possible p o ec i e e ec o he sul a e me aboli es o TYR and HT, in compa ison wi h he pa en
30
compounds, agains he oxida i e damage o in es inal mucosa due o oxidized choles e ol exposu e in he human colon adenoca cinoma
cell line, Caco-2. A e con luence, hese cells spon aneously unde go ull di e en ia ion in i o wi h en e ocy e-like ea u es 16. Caco-2
cells ha e been ecognized as a sui able model o e alua ing he e ec o nu ien componen s, o bo h no mal die a y cons i uen s and
oxican s, as oxidizing agen s 17. La ge amoun s o lipid oxida ion p oduc s become a ailable, o bo h exogenous and endogenous o igin,
a he le el o he in es inal mucosa. Die a y oxys e ols, de i ed om choles e ol deg ada ion and oxida ion a e p olonged s o age o
35
cooking o oods ich in choles e ol, ha e ecen ly been shown o con ibu e o he onse and u he de elopmen o oxida i e s ess and
in lamma ion ela ed in es inal diseases 18-19. The majo oxys e ols ound in ood may con ibu e o oxida i e unbalance o he in es inal
epi helium by inducing he gene a ion o eac i e oxygen species (ROS) 18, 20. Ou pu pose was o in es iga e he abili y o sul a e
me aboli es o HT and TYR o ac as an ioxidan s coun e ac ing he oxys e ols induced changes o he cellula edox s a e and compa e
hem wi h hei pa en compounds. Fo his pu pose, we syn hesized sul a e me aboli es o HT and TYR using chemical me hodology
40
and e alua e hei up ake/s abili y in Caco-2 monolaye s. Cy o oxici y, p oduc ion o MDA and ROS species, le els o glu a hione and
glu a hione pe oxidase ac i i y we e measu ed o assess he p o ec ing e ec o he sul a e me aboli es in compa ison wi h he ( hei )
pa en oli e ( emo e) phenolic compounds.
CREATED USING THE RSC ARTICLE TEMPLATE (VER. 3.0) - SEE WWW.RSC.ORG/ELECTRONICFILES FOR DETAILS
ARTICLE TYPE www. sc.o g/xxxxxx | XXXXXXXX
2
| Jou nal Name, [yea ],
[ ol]
, 00–00
This jou nal is © The Royal Socie y o Chemis y [yea ]
Ma e ials and me hods
P epa a ion o oxidized choles e ol
Oxidized choles e ol was p epa ed essen ially as p e iously desc ibed 21. In b ie , samples o 2 ml (2ml aliquo s) o pu e choles e ol
(Sigma Ald ich, S . Louis, MO) solu ion (5 mg/ml in E OH) we e d ied down in o ound-bo omed glass es ubes unde acuum and
5
hea ed in a 140 °C oil ba h in ai o 3 h. The oxidized mix u e was sepa a ed and analysed by GC-MS o he de e mina ion o he
ela i e oxys e ols. B ie ly, 2 L o he mix u e was dilu ed in 2 mL o E OH (1: 1000 dilu ion). A e e apo a ing unde a ni ogen
s eam, 50 L o py idine (Sigma Ald ich) and 50 L o N,O-Bis( ime hylsilyl) i luo oace amide wi h ime hylchlo osilane
(BSTFA:TMCS; 99: 1) (Sigma Ald ich) we e added, mixed and kep a 60 °C o 45 min. The de i a ized sample (1.5 L) was injec ed
in o an Agilen (Waldb onn, DE) GC-MS in spli less mode and he column empe a u e was p og ammed s a ing om 70 °C o 250 °C
10
(10 °C/minu e), a e up o 290 °C (5 °C/min) main ained o 10 min, ending a 300 °C (2 °C/min) o 5 min (du a ion abou 45 min
o al). The helium low was se a 1.3 mL/min. The speci ic pa ame e s o he ins umen we e as published by Calde on-San iago e al.
22 Spec a we e acqui ed in scan mode.
GS-MS analysis demons a ed ha he mix u e con ained 58.9% o choles e ol, 13.5% o 7-ke ocholes e ol, 9.54% o 7-
hyd oxycholes e ol, 5.6% o 6-hyd oxycholes e ol, 5.87% o 7-hyd oxycholes e ol, 4.5% o choles a-4,6-dien-3-ol and 2.1% o 3-
15
ke o-4-choles ene.
Syn hesis o sul a e me aboli es
Gene al me hods.
HT and HT ace a e we e ob ained om Sep ox Bio ech (Mad id, Spain), TYR om Sigma Ald ich. All o he chemicals ob ained om
comme cial sou ces we e used wi hou u he pu i ica ion, unless o he wise no ed. All eac ions we e moni o ed by TLC on p ecoa ed
20
Silica-Gel 60 pla es F254, and de ec ed by hea ing wi h Mos ain (500 mL o 10% H2SO4, 25g o (NH4)6Mo7O24•4H2O, 1g
Ce(SO4)2•4H2O). P oduc s we e pu i ied by lash ch oma og aphy wi h Me ck Silica gel 60 (200-400 mesh). High esolu ion mass
spec a we e ob ained on an ESI/quad upole Au oSpec-Q mass spec ome e . NMR spec a we e eco ded on 300 o 500 MHz
spec ome e s, a oom empe a u e o solu ions in CDCl3, o D2O. Chemical shi s a e e e ed o he sol en signal. Me aboli es we e
pu i ied by ch oma og aphy wi h Re e se Phase-C18 Silica gel. Da a we e p ocessed using manu ac u e so wa e, aw da a we e
25
mul iplied by shi ed exponen ial window unc ion p io o Fou ie ans o m, and he baseline was co ec ed using polynomial i ing.
Gene al p ocedu e o he mic owa e-assis ed O-sul a ion.
Mic owa e based sul a ion eac ions we e pe o med using a mic owa e syn hesize in sealed eac ion essels. Phenolic de i a i es (1.0
equi ), sul u ioxide– ime hylamine complex, SO3.NMe3, (5 equi pe OH; being his complex p e iously washed wi h H2O, MeOH,
and CH2Cl2 and d ied unde high acuum) and a magne ic s i e ba we e placed in a 2-5 mL mic owa e eac ion ial and i ed wi h a
30
sep um, which was hen pie ced wi h a needle. The closed ial was hen e acua ed in high acuum o 2 h. The mix u e was dissol ed in
d y CH3CN (2.0 mL) and NE 3 (0.3-1.0 mL) was hen added. Reac ion mix u e was subjec ed o mic owa e adia ion o 20–40 min
(depending on he compound) a 100 ºC (50-60W a e age powe ). MeOH (1 mL) and CH2Cl2 (1 mL) we e added, and he solu ion was
laye ed on he op o a Sephadex LH-20 ch oma og aphy column which was elu ed wi h CH2Cl2/MeOH (1:1) o ob ain he co esponding
ie hylammonium sal as a whi e powde (94–98% yield).
35
T ie hylamine, 4-(2-(bu y yloxy)e hyl)phenyl sul a e sal (7). Ty osol bu y a e 6 23-24 (70 mg, 0.33 mmol) and SO3.NMe3 (233 mg,
1.7 mmol) we e submi ed unde sul a ion condi ions o 20 min. TLC (E hyl ace a e: MeOH, 10:1) showed he o ma ion o a majo
p oduc and comple e consump ion o he ini ial ma e ial. Sol en s we e emo ed and he c ude ex ac was pu i ied by sephadex LH-20
(CH2Cl2:MeOH, 1:1) o a o d 7 (92 mg, 98%) as a whi e powde . 1H-NMR (300 MHz, D2O) : 6.72, 7.18 (2d, 4H, J = 8.7 Hz, Ha om),
40
4.24 ( , 2H, CH2OAc), 3.10 (q, 6H, -CH2CH3), 2.88 ( , 2H, CH2A ), 2.19 ( , 2H, J = 7.5Hz, CH2), 1.45 (m, 2H, CH2), 1.18 ( , 9H,
CH2CH3), 0.74 ( , 3H, CH3); 13C-NMR (125 MHz, D2O) δ: 177.1 (CO), 150.0, 136.2, 130.3 (2x CHa om), 121.3 (2x CHa om), 65.4
(CH2OAc), 46.5, 36.0 (CH2A ), 34.0, 18.3, 12.6, 8.0 (CH3). ESI-HRMS (ES-) Calcd. o C12H15O6S (M-H) 287.0589, Found: 287.0594.
Po assium 4-(2-hyd oxye hyl)phenyl sul a e (5). Compound 7 (97 mg, 0.32 mmol) was dissol ed in MeOH (10 mL) and K2CO3 (90
45
mg, 0.66 mmol) was added. The eac ion mix u e was s i ed a oom empe a u e o 24 h and hen neu alized wi h IR 120 H+ esin.
Sol en was hen emo ed in acuum and he c ude ex ac was pu i ied by an RP-C18 column elu ed wi h H2O: MeOH ( om 100:0 o
70:30). F ac ions con aining he desi ed p oduc we e concen a ed and eeze-d ied a o ding compound 5 as a whi e solid (68 mg,
94%). 1H-NMR (400 MHz, D2O) : 7.18, 6.86 (2d, 4H, J = 8.4 Hz, Ha om), 3.78, 2,78 (2 , 4H, J = 6.7 Hz, CH2OH, CH2A ); 13C-
NMR (75 MHz, D2O) δ: 157 (Cq), 130.3 (2x CHa om), 129.8 (Cq), 117.1 (2x CHa om), 63.0 (CH2OH), 36.9 (CH2A ). ESI-HRMS (ES-)
50
Calcd. o C8H9O5S (M-H) 217.0171, Found: 217.0171.
3-(( e -bu yldime hylsilyl)oxy)-4-hyd oxyphene hyl ace a e (9) and 4-(( e -bu yldime hylsilyl)oxy)-3-hyd oxyphene hyl ace a e
(10). To a solu ion o hyd oxy y osol ace a e 8 23-24 (223 mg, 1.13 mmol) in DMF (anhyd ous, 3 mL) cooled in an ice-wa e ba h unde
a gon we e added sequen ially e -bu yldime hylsilyl- i luo ome hanesul ona e (TBDMSOT , 287 L, 1.25 mmol, 1.10 equi ) and
55
diisop opyle hylamine ( i-P 2Ne , 265 L, 1.52 mmol, 1.35 equi ). The mix u e was allowed o s i o 30 min a 0 ºC, and TLC (hexane:
Jou nal Name
Ci e his: DOI: 10.1039/c0xx00000x
www. sc.o g/xxxxxx
Dynamic A icle Links
►
ARTICLE TYPE
This jou nal is © The Royal Socie y o Chemis y [yea ]
Jou nal Name, [yea ],
[ ol]
, 00–00 |
3
e hyl ace a e 3:1) a ha poin indica ed ha he eac ion was comple e. The pale yellow eac ion mix u e was dilu ed wi h E OAc (100
mL), cas in o a sepa a o y unnel, and washed wi h wa e (2x50 mL), b ine (50 mL), and he o ganic phase was d ied (Na2SO4).
Fil a ion and concen a ion in acuum a o ded he c ude ex ac ha was pu i ied by lash column ch oma og aphy (hexane:e hyl
ace a e om 15:1 o 10:1) o a o d 9 and 10 (314 mg, 90%, powde ) like a egioisome ic mix u e in a io ~ 1:1 . 1H NMR (400 MHz,
CDCl3) δ 6.88 (d, 1H, J = 8.1 Hz, Ha om), 6.83 (s, 1H, Ha om), 6.77 (d, 1H, J = 8.4 Hz, Ha om), 6.73 (d, 1H, J = 8.4 Hz, Ha om),
5
6.71(s, 1H, Ha om), 6.62 (d, 1H, J = 8.1 Hz, Ha om ), 5.52, 5.45 (2s, 2H, 2xOH), 4.26 ( , 2H, J = 6.7 Hz, CH2OAc), 4.24 ( , 2H,
J = 6.4 Hz, CH2OAc), 2.86 ( , 2H, J = 6.7 Hz, CH2A ), 2,84 ( , 2H, J = 6.4 Hz, CH2A ), 2.07-2.05 (2s, 6H, CH3C=O), 1.05, 1.03
(2s, 18H, C(CH3)3 x2), 0.30, 0.29 (2s, 12H, -Si(CH3)2 x2); 13C-NMR (125 MHz, CDCl3) δ: 171.1, 171.0 (C=O), 147.1, 145.9, 142.3,
141.0, 131.8, 129.6 (Cqa om), 122.4, 120.2, 118.6, 117.7, 115.4, 114.8 (CHa om), 65.2, 65.0 (CH2OAc), 34.5 (2x CH2A ), 25.7
(C(CH3)3), 21.0, 20.9 (CH3C=O), 18.2 (C(CH3)3), -4.2 (Si(CH3)2); HRMS (ES+) Calcd. o C16H26O4NaSi (M+Na) 333.1498, Found:
10
333.1508.
T ie hylamine, 5-(2-ace oxye hyl)-2-(( e -bu yldime hylsilyl)oxy)phenyl sul a e sal (11) and ie hylamine, 4-(2-ace oxye hyl)-2-
(( e -bu yldime hylsilyl)oxy)phenyl sul a e sal (12). Regioisome ic mix u e o compounds 9 and 10 (157 mg, 0.506 mmol) and
SO3.NMe3 (351 mg, 2.52 mmol) we e submi ed unde sul a ion condi ions o 2x20 min. TLC (E hyl ace a e:MeOH 10:1) showed he
15
o ma ion o a majo p oduc and comple e consump ion o he s a ing ma e ial. Sol en s we e emo ed and c ude was pu i ied by
sephadex LH-20 in a sol en mix u e o CH2Cl2: MeOH 1:1 o a o d 11 and 12 (231 mg, 94%, powde ) like a egioisome ic mix u e in
a io ~ 1:1. 1H-NMR (400 MHz, CDCl3) δ: 7.50 (d, 1H, J = 7.9 Hz, Ha om), 7.46 (s, 1H, Ha om), 6.82 (d, 1H, J = 8.2 Hz, Ha om), 6.78
(d, 1H, J = 8.2 Hz, Ha om), 6.73 (d, 1H, J = 7.9 Hz, Ha om), 6.72 (s, 1H, Ha om), 4.20 ( , 4H, J = 7.08 Hz, CH2OAc), 3.10-3.00 (dq,
12H, CH2CH3), 2.83 ( , 2H, J = 7.1 Hz, CH2A ), 2.82 ( , 2H, J = 7.05 Hz, CH2A ), 2.04, 2.03 (2s, 6H, CH3C=O), 1.26 ( , 18H, CH2CH3),
20
1.00, 0.99 (2s, 18H, C(CH3)3 x2), 0.21, 0.20 (2s, 12H, -Si(CH3)2 x2); 13C-NMR (125 MHz, CDCl3) δ: 171.0, 170.9 (C=O), 146.8, 145.6,
143.9, 142.8, 134.0, 130.7 (Cqa om), 124.5, 122.4, 121.9, 121.8, 121.6, 121.0 (CHa om), 65.1 (CH2OAc), 46.3 (CH2CH3), 34.5,
(CH2A ), 25.7 (C(CH3)3), 21.0 (CH3C=O), 18.8 (C(CH3)3), 8.8 (CH2CH3), -4.2 (Si(CH3)2); ESI-HRMS (ES-) Calcd. o C16H25O7SiS (M-
H) 389.1090, Found: 389.1092.
25
Po assium 2-hyd oxy-4-(2-hyd oxye hyl)phenyl sul a e (3) and po assium 2-hyd oxy-5-(2-hyd oxye hyl)phenyl sul a e (4).
Regioisome ic mix u e o 11 and 12 (231 mg, 0.47 mmol), po assium luo ide (KF,55 mg, 0.94 mmol) and po assium ca bona e (K2CO3,
130 mg, 0.94mmol) we e dissol ed in MeOH (10 mL). The eac ion mix u e was s i ed a oom empe a u e o 18 h and sol en was
hen emo ed in acuum. The c ude ex ac was pu i ied by column ch oma og aphy wi h RP-C18 silica gel elu ing wi h H2O: MeOH
( om 100:0 o 70:30). F ac ions con aining he desi ed p oduc we e concen a ed and eeze-d ied a o ding compounds 3 and 4 (115
30
mg, 90%, whi e powde ) like a egioisome ic mix u e in a io ~ 1:1. 1H-NMR (300 MHz, D2O) : 7.21 (d, 2H, J = 8.0 Hz, Ha om), 7.17
(s, 1H, Ha om), 6.98 (d, 1H, J = 8.5 Hz, Ha om), 6.88 (d, 1H, J = 8.5 Hz, Ha om), 6.80 (s, 1H, Ha om), 6.70 (d, 1H, J = 8.0 Hz, Ha om),
3.76-3.69 (m, 4H, CH2OAc), 2.73-2.70 (m, 4H, CH2A ); 13C-NMR (125 MHz, D2O) δ: 149.4, 147.4, 139.0, 138.4, 137.8, 130.7, 127.6,
123.0, 122.6, 120.0, 118.2, 117.6, 62.6, 62.4 (CH2OAc), 37.4, 36.9 (CH2A ). HRMS-ESI (ES-) Calcd. o C8H9O6S (M-H) 233.0120,
Found: 233.0126.
35
Cell cul u e
Cell cul u e ma e ials we e pu chased om In i ogen (Milano, I aly). Caco-2 cells we e ob ained om he Eu opean Collec ion o Cell
Cul u es (ECACC, Salisbu y UK) and g own in Dulbecco’s modi ied Eagle’s medium (DMEM), supplemen ed wi h 2.5% o hea -
inac i a ed bo ine se um and 100U/mL penicillin and 100 μg/mL s ep omycin, a 37 °C unde a humidi ied a mosphe e o 95% ai and
40
5% CO2. Fo expe imen al s udies Caco-2 cells, a passage 45–60, we e pla ed a a densi y o abou 1 × 105/mL and used 21 days pos
seeding
Cy o oxic ac i i y
The cy o oxic e ec caused by he exposu e o inc easing concen a ions o oxidized choles e ol and he p o ec i e e ec o HT, TYR,
and sul a e me aboli es was assessed on Caco-2 cells, seeded in 24-well pla es, by he Neu al Red me hod 25. Cells we e exposed o
45
oxidized choles e ol (0–175 μg/mL) in comple e medium and incuba ed o 24 h. In o de o assess he p o ec i e e ec o he phenolic
compounds cells we e p e ea ed wi h he es ed compounds (2,5-10 µM in wa e solu ion, 30 min) p io o oxidized choles e ol exposu e
(100 μg/mL o 24 h). A e incuba ion, he medium was emo ed; a Neu al Red Solu ion (Sigma Ald ich) (0.033% in medium) was
hen added o he wells o de e mine cell iabili y. A e 30 min o incuba ion, he Neu al ed solu ion was ca e ully emo ed and cells
quickly insed wi h PBS. The inco po a ed dye was hen solubilised in Neu al Red Solubilisa ion Solu ion, ace ic acid/e hanol /wa e
50
CREATED USING THE RSC ARTICLE TEMPLATE (VER. 3.0) - SEE WWW.RSC.ORG/ELECTRONICFILES FOR DETAILS
ARTICLE TYPE www. sc.o g/xxxxxx | XXXXXXXX
4
| Jou nal Name, [yea ],
[ ol]
, 00–00
This jou nal is © The Royal Socie y o Chemis y [yea ]
(1/45/50, / / ), and he abso bance was measu ed a 540 nm.
De e mina ion o MDA
MDA le els we e de e mined in he medium o ea ed cells by he TBARS es wi h HPLC quan i ica ion, using he me hod desc ibed
by Templa e al. 26, wi h some modi ica ions. B ie ly, 100 μL o 10% ichlo oace ic acid (TCA, Sigma Ald ich) was added o 400 μL o
5
he medium, samples we e mixed and le a oom empe a u e. A e 20 min, 200 μL o 2- hioba bi u ic acid (TBA, Sigma Ald ich)
(0.6%) we e added; samples we e incuba ed a 90 °C o 45 min and hen cen i uged a 5000 x g o 15 min a 4 °C. Aliquo s o he
supe na an we e injec ed in o an Agilen 1100 HPLC sys em (Agilen Technologies, San a Cla a, CA) equipped wi h a diode-a ay
de ec o (HPLC–DAD) and sepa a ion was achie ed using a Va ian (Middelbu g, The Ne he lands) Ine sil 5 ODS-2, 150 × 4.6 mm
column; he mobile phase was a mix u e o KH2PO4 50 mM pH 7/MeOH (65/35, / ) a a cons an low a e o 1 mL/min. The o ma ion
10
o he MDA–TBA adduc was e ealed measu ing i s abso bance a 532 nm. A s anda d cu e was p epa ed using a 1,1,3,3,-
e ae hoxyp opane (TEP, Sigma Ald ich) solu ion in PBS (0.05–10 μM).
ROS p oduc ion in Caco-2 cells
In acellula ROS p oduc ion was moni o ed by adding he 2',7'-dichlo odihyd o luo escein diace a e (H2-DCF-DA, Sigma Ald ich),
acco ding o Dinicola e al. 27, in Caco-2 cells exposed o oxidized choles e ol (75 μg/mL) in comple e medium and incuba ed o 0-180
15
min and in cells p e ea ed wi h he es ed phenolic compounds (5-25 µM in wa e solu ion, 30 min), p io o exposu e o oxidized
choles e ol (75 μg/mL o 30 min), wi h some modi ica ions. A e incuba ion he cul u e medium was eplaced wi h PBS and cells we e
loaded wi h 10 µM H2-DCF-DA o 30 min. A e incuba ion, PBS and H2-DCF-DA we e emo ed and he cells we e washed wice.
Inc ease in cell luo escence was measu ed a exci a ion and emission wa eleng hs o 490 and 520 nm, espec i ely, using an In ini e 200
au o mic opla e eade (Tecan, Salzbu g, Aus ia), a 25 °C.
20
Glu a hione (GSH) le el and Glu a hione pe oxidase (GPx) ac i i y
To assess he changes in he le els o GSH and GPx ac i i y, cells we e seeded in pla e dishes and exposed o oxidized choles e ol
(75 μg/mL) in comple e medium o 0-24 h. In o de o assess he e ec o HT, TYR, HT-S and TYR-S, cells we e p e ea ed wi h he
es ed compounds (5-25 µM in wa e solu ion, 30 min) p io o exposu e o oxidized choles e ol 75 μg/mL o 30 min o de e mine GSH
le el and o 18 h o measu e GPx ac i i y. A he end o incuba ion ime, cells we e washed wi h PBS, and subsequen ly sc aped in o
25
500 μL o 5% me aphospho ic acid. Samples we e hen sonica ed and cen i uged a 10000 × g o 20 min a 4 ºC; supe na an s we e
collec ed and used o de e mine GSH le el and GPx ac i i y, using Glu a hione Assay Ki and Glu a hione pe oxidase Assay Ki
(Cayman Chemical Company, Ann A bo , USA) acco ding o he manu ac u e ’s ins uc ions.
S a is ical analysis
Da a a e exp essed as means ± S.D (n=12 o each sample/condi ion). The s a is ical e alua ion o he esul s was pe o med by analysis
30
o a iance (ANOVA) ollowed by a Bon e oni pos -hoc es using G aphPad InS a e sion 3.05 (G aphPad So wa e, San Diego, CA,
USA).

Jou nal Name
Ci e his: DOI: 10.1039/c0xx00000x
www. sc.o g/xxxxxx
Dynamic A icle Links
►
ARTICLE TYPE
This jou nal is © The Royal Socie y o Chemis y [yea ]
Jou nal Name, [yea ],
[ ol]
, 00–00 |
5
Resul s
Syn hesis o HT and TYR sul a e me aboli es has been ca ied ou using a p o ec ion-dep o ec ion s a egy oge he wi h he use o
mic owa es in he c i ical sul a ion s ep. In he case o TYR, he p ima y alcohol was acyl- p o ec ed using immobilized lipase No ozym
435® and inyl bu y a e in e -bu yl me hyl e he (98 % yield) (Scheme 1). Nex , mic owa e-assis ed sul a ion was pe o med by
ea men wi h SO3.NMe3 complex and ie hylamine in ace oni ile a 100 ºC (98% yield). Final dep o ec ion wi h K2CO3 in MeOH
5
a o ded y osol sul a e 5 in good yield (94%).
10
Scheme 1 P epa a ion o y osol sul a e 5
15
Mono-sul a ed hyd oxy y osol de i a i es 3 and 4 we e p epa ed as a egioisome ic mix u e using a syn he ic s a egy simila o ha o
TYR. In his case, hyd oxy y osol ace a e 8 was mono-silyl p o ec ed o a oid disul a ed p oduc s di icul o sepa a e om he mono-
sul a ed de i a i es (Scheme 2).
20
25
Scheme 2 P epa a ion o hyd oxy y osol sul a e me aboli es 3 and 4
Random TBDMS-p o ec ion o HT ace a e 8 and subsequen ch oma og aphic sepa a ion a o ded a 1:1 egioisome ic mix u e o he wo
possible mono-phenolic compounds 9 and 10. The same sul a ion eac ion condi ions used be o e we e applied o gi e 94% yield o a 1:1
mix u e o isome s 11 and 12. Finally, ace yl and silyl dep o ec ion was ca ied ou in one s ep using KF and K2CO3 in MeOH o ob ain a
30
mix u e o mono-sul a ed hyd oxy y osol de i a i es 3 and 4 (90% yield).
To in es iga e he po en ial p o ec i e e ec o he HT and TYR sul a e me aboli es, in compa ison wi h hei pa en compounds, agains
he p o-oxidan e ec o oxidized choles e ol in in es inal cells, Caco-2 monolaye s we e ea ed o 24 h wi h a mix u e ob ained om
he oxida ion o choles e ol a 140 °C o 3 h. In hese oxidizing condi ions hal o he ini ial choles e ol was u ned in o oxida ion
p oduc s ( epo ed in he me hods sec ion). T ea men wi h g owing concen a ion o he mix u e induced p oduc ion o MDA and cell
35
dea h (Fig. 2), indica ing he p esence o oxida i e cell inju y.
40
CREATED USING THE RSC ARTICLE TEMPLATE (VER. 3.0) - SEE WWW.RSC.ORG/ELECTRONICFILES FOR DETAILS
ARTICLE TYPE www. sc.o g/xxxxxx | XXXXXXXX
6
| Jou nal Name, [yea ],
[ ol]
, 00–00
This jou nal is © The Royal Socie y o Chemis y [yea ]
5
10
15
Fig.2 Values o MDA (2A) and cell iabili y (2B) measu ed in Caco-2 cells a e 24 h incuba ion wi h di e en concen a ions o oxidized choles e ol.
* = p<0.05 e sus con ol
20
P e ea men wi h he phenolic compounds signi ican ly inhibi ed he inc ease o MDA (Fig. 3) in Caco-2 cells ea ed wi h 75 g/mL o
he oxidizing mix u e, he highes amoun able o induce a signi ican p oduc ion o MDA bu no cell dea h. MDA educ ion was
signi ican om 2.5 M o HT-S and om 5 M o HT; TYR and i s sul a e me aboli e exe ed he same e icacy s a ing om 2.5 M.
25
30
35
40
45
50
Fig.3 Values o MDA measu ed in Caco-2 cells a e 24 h incuba ion wi h 75 g/mL oxidized choles e ol and p e ea ed (30 min) wi h TYR, HT, HT
sul a e me aboli es 3-4 (HT-S) and TYR sul a e me aboli e 5 (TYR-S) (2.5-10 M). * = p<0.05 e sus con ol, a = p<0.05 e sus oxidized choles e ol
ea ed (Ox).
A
B
0
50
100
150
200
250
300
Con ol
25
50
75
100
125
150
175
MDA (% o he con ol)
Oxidized choles e ol (µg/ml)
*
*
*
*
*
0
40
80
120
Con ol
25
50
75
100
125
150
175
Cell iabili y (% o he con ol)
Oxidized choles e ol (µg/ml)
*
*
*
*
0
40
80
120
160
Con ol
Ox
Ox + 2,5
Ox + 5
Ox + 10
MDA (% o he con ol)
Compound (M)
HT
HT-S
*
a
aa
aa
0
40
80
120
160
Con ol
Ox
Ox + 2,5
Ox + 5
Ox + 10
MDA (% o he con ol)
Compound (M)
TYR
TYR-S
*
a
a
a
a
a
a
Jou nal Name
Ci e his: DOI: 10.1039/c0xx00000x
www. sc.o g/xxxxxx
Dynamic A icle Links
►
ARTICLE TYPE
This jou nal is © The Royal Socie y o Chemis y [yea ]
Jou nal Name, [yea ],
[ ol]
, 00–00 |
7
Nex we examined he abili y o HT, TYR and hei co esponding sul a e me aboli es o p o ec cells agains dea h in Caco-2 cells
ea ed wi h 100 g/mL o oxidized choles e ol, he lowes amoun able o induce a signi ican cell dea h (Fig. 4). We obse ed ha HT
p ese ed cell iabili y om he concen a ion o 5 M whe eas HT sul a es 3-4 showed p o ec ion a he 10 M concen a ion. In he
case o TYR and i s sul a e de i a i e, bo h imp o ed cell iabili y a 10 M concen a ion.
5
10
15
20
25
Fig.4 Cell iabili y measu ed in Caco-2 cells a e 24 h incuba ion wi h 100g/mL oxidized choles e ol and p e ea ed (30 min) wi h TYR, HT o hei
sul a e me aboli es (2.5-10 M). * = p<0.05 e sus con ol, a=p<0. 05 e sus oxidized choles e ol ea ed (Ox).
30
35
40
45
0
20
40
60
80
100
120
Con ol
OX
OX + 2,5
OX + 5
OX + 10
Cell iabili y (% o he con ol)
Compound (M)
HT
HT-S
*
aa
a
***
0
20
40
60
80
100
120
Con ol
OX
OX + 2,5
OX + 5
OX + 10
Cell iabili y (% o he con ol)
Compound (M)
TYR
TYR-S
aa
**
**
*
CREATED USING THE RSC ARTICLE TEMPLATE (VER. 3.0) - SEE WWW.RSC.ORG/ELECTRONICFILES FOR DETAILS
ARTICLE TYPE www. sc.o g/xxxxxx | XXXXXXXX
8
| Jou nal Name, [yea ],
[ ol]
, 00–00
This jou nal is © The Royal Socie y o Chemis y [yea ]
5
10
15
20
Fig.5 ROS le el, exp essed as % o he con ol samples, in Caco-2 cells, ea ed wi h 75 g/ml oxidized choles e ol o di e en incuba ion imes (5A) o
p e ea ed (30 min) wi h TYR, HT o hei sul a e me aboli es (5-25 M) and ea ed wi h oxidized choles e ol o 30 min (5B), exposed o 2',7'-
dichlo odihyd o luo escein diace a e H2-DCF-DA (10 mM) o 30 min. * = p<0.05 e sus con ol, a = p<0.05 e sus oxidized choles e ol ea ed (Ox), °=
p<0.05 e sus 0 min
25
The oxidizing ac ion o he mix u e o oxidized choles e ol was hen in es iga ed moni o ing he al e a ion o he cellula edox s a us
wi h ime: a e 30 min o incuba ion a signi ican p oduc ion o ROS was obse ed in he cells ea ed wi h he oxidized choles e ol in
compa ison wi h he con ol (Fig. 5A). Nex , we measu ed ROS p oduc ion a 30 min, a e p e ea men wi h he di e en phenolic
compounds (5, 10, 25 M). We obse ed ha ROS p oduc ion was signi ican ly lowe om he concen a ion o 10M o all he es ed
30
compounds, excep o TYR-S (Fig. 5B).
A e 30 min o incuba ion wi h he oxidized choles e ol, ROS p oduc ion was associa ed wi h a signi ican educ ion o Caco-2 cellula
GSH, a ound 40% o he ini ial alue, as shown in Figu e 6A. The le el o GSH inc eased wi h ime, eaching he con ol alue a 3/6 h,
o dec ease again he ea e . P e ea men wi h bo h HT and TYR p ese ed he con ol le el o GSH a all he es ed concen a ions and
hei sul a e me aboli es exe ed a compa able e icacy (Fig. 6B). In e es ingly, none o he es ed compounds was able o al e GSH le el
35
when incuba ed alone (25M) in he expe imen al condi ions used (p>0.5 e sus con ol).
Wi h espec o he conside ed pa ame e s, we did no obse e any concen a ion dependen p o ec i e e ec o he es ed phenolic
compounds, no signi ican di e ences among pa en compounds and me aboli es.
40
45
B
A
0
50
100
150
200
250
Con ol
Ox
Ox + 5
Ox + 10
Ox + 25
ROS le el (% o he con ol)
Compound (M)
HT
HT-S
*
a,* a
*
*a,* a,*
0
50
100
150
200
Con ol
Ox
Ox + 5
Ox + 10
Ox + 25
ROS le el (% o he con ol)
Compound (M)
TYR
TYR-S
*
aaa
*
**
0
50
100
150
0
30
60
180
ROS le el (%o he con ol)
Incuba ion ime (min)